Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1984-03-22
1986-04-01
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
A61K 3158
Patent
active
045798443
ABSTRACT:
A pharmaceutical composition for topical treatment of cutaneous disorders or disruptions characterized by skin inflammation or hyperproliferative epidermal activity comprises the combination of a topically active anti-inflammatory corticosteroid and a non-steroidal anti-inflammatory agent which is an inhibitor of prostaglandin synthetase selected from the group consisting of the hydratropic acid derivatives; acetylsalicylic acid; the pyrazolon derivatives; the fenamic acid derivatives; the aroyl-substituted pyrroles and the substituted arylacetohydroxamic acids in a pharmaceutically acceptable topical vehicle. Treatment of above cutaneous disorders may also be effected by concurrent therapy using separate applications of corticosteroid and non-steroid.
Marvel John R.
Mezick James A.
Rovee David T.
Friedman Stanley J.
Johnson & Johnson
Lambert Benjamin F.
LandOfFree
Topical anti-inflammatory drug therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Topical anti-inflammatory drug therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Topical anti-inflammatory drug therapy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1084601